A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms
Interventions: OTHER: No intervention
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Hoffmann-La Roche|Novartis|AstraZeneca|Pfizer|Celgene